Semba Charles Pauling has filed 8 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 3355 shares of DiaMedica Therapeutics Inc. ($DMAC) on January 02, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | DiaMedica Therapeutics Inc. | $DMAC | Semba Charles Pauling | Not found | A | Common Stock | 3355 | $8.42 | 47,963.0000 | 52,077,439 | 7.52% | 0.01% |
| June 1, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Semba Charles Pauling | Director | A | Stock Option (right to buy) | 32162 | $0.00 | 32,162.0000 | 42,855,660 | 9999.99% | 0.08% |
| Jan. 2, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Semba Charles Pauling | Director | A | Voting Common Shares, no par value per share | 5290 | $5.34 | 44,608.0000 | 0 | 13.45% | 0.00% |
| June 1, 2024 | DiaMedica Therapeutics Inc. | $DMAC | Semba Charles Pauling | Director | A | Stock Option (right to buy) | 28472 | $0.00 | 28,472.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | DiaMedica Therapeutics Inc. | $DMAC | Semba Charles Pauling | Director | A | Voting Common Shares, no par value per share | 9375 | $2.80 | 39,318.0000 | 0 | 31.31% | 0.00% |
| June 23, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Semba Charles Pauling | Director | P | Voting Common Shares, no par value per share | 12787 | $3.91 | 29,943.0000 | 0 | 74.53% | 0.00% |
| June 1, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Semba Charles Pauling | Director | A | Stock Option (right to buy) | 16968 | $0.00 | 16,968.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Semba Charles Pauling | Director | A | Voting Common Shares, no par value per share | 17156 | $1.53 | 17,156.0000 | 0 | 9999.99% | 0.00% |